Export 13 results:
Author Title [ Type(Desc)] Year
Filters: Author is Lambin, Philippe  [Clear All Filters]
Journal Article
Roelofs E, Persoon L, Nijsten S, Wiessler W, Dekker A, Lambin P. Benefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial. Radiotherapy and Oncology. 2013;108(1):174 - 179. doi:10.1016/j.radonc.2012.09.019.
Nalbantov G, Kietselaer B, Vandecasteele K, et al. Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients. Radiotherapy and Oncology. 2013;109(1):100 - 106. doi:10.1016/j.radonc.2013.08.035.
Aerts HJWL, Velazquez ERios, Leijenaar RTH, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006. doi:10.1038/ncomms5006.
Velazquez ERios, Hoebers F, Aerts HJWL, et al. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging. Radiother Oncol. 2014;113(3):324-30. doi:10.1016/j.radonc.2014.09.005.
Roelofs E, Dekker A, Meldolesi E, van Stiphout RGPM, Valentini V, Lambin P. International data-sharing for radiotherapy research: an open-source based infrastructure for multicentric clinical data mining. Radiother Oncol. 2014;110(2):370-4. doi:10.1016/j.radonc.2013.11.001.
Loon J, Janssen MHM, Oellers MC, et al. PET imaging of hypoxia using [18F]HX4: a phase I trial. European Journal of Nuclear Medicine and Molecular Imaging. 2010;37(9):1663 - 1668. doi:10.1007/s00259-010-1437-x.
Even AJG, van der Stoep J, Zegers CML, et al. PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes. Radiother Oncol. 2015;116(2):281-6. doi:10.1016/j.radonc.2015.07.013.
Eekers DBP, Ven Lin 't, Deprez S, et al. The posterior cerebellum, a new organ at risk?. Clinical and Translational Radiation Oncology. 2018;8:22 - 26. doi:10.1016/j.ctro.2017.11.010.
Dubois LJ, Lieuwes NG, Janssen MHM, et al. Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging. Proceedings of the National Academy of Sciences. 2011;108(35):14620 - 14625. doi:10.1073/pnas.1102526108.
Carvalho S, Leijenaar RTH, Velazquez ERios, et al. Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer. Acta Oncol. 2013;52(7):1398-404. doi:10.3109/0284186X.2013.812795.
Starmans MHW, Chu KC, Haider S, et al. The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer. Radiotherapy and Oncology. 2012;102(3):436 - 443. doi:10.1016/j.radonc.2012.02.002.
Velazquez ERios, Aerts HJWL, Gu Y, et al. A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists' delineations and with the surgical specimen. Radiother Oncol. 2012;105(2):167-73. doi:10.1016/j.radonc.2012.09.023.
Oberije C, De Ruysscher D, Houben R, et al. A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients. Int J Radiat Oncol Biol Phys. 2015;92(4):935-44. doi:10.1016/j.ijrobp.2015.02.048.